Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne Kunnari"'
Autor:
Maarit Jokela, Eija Kellokoski, Anne Kunnari, Y. Antero Kesäniemi, Sanna Mäkelä, Sohvi Hörkkö
Publikováno v:
Metabolism. 58:1572-1580
Emerging evidence indicates the potential involvement of ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, in low-grade inflammatory diseases such as obesity and atherosclerosis. The goal of the present study was to use cell
Publikováno v:
Inflammation Research. 58:54-59
Apolipoprotein (apo) E phenotype has been associated with inflammation markers. The determinants of these associations and the relationship between novel inflammation marker, resistin, and apoE phenotype are studied here.Middle-aged subjects of the p
Autor:
Maarit Jokela, Olavi Ukkola, Y. Antero Kesäniemi, Anna Karjalainen, Anne Kunnari, J. Heikkinen, Merja Santaniemi
Publikováno v:
Metabolism. 57:1509-1515
The effects of estrogen replacement therapy (ERT) to cardiovascular disease risk are still unclear. Low adiponectin and high resistin plasma concentrations are reported to be associated with atherosclerosis. However, it is not known how ERT affects p
Publikováno v:
Regulatory Peptides. 149:56-59
Objective: To examine the relation of the single nucleotide polymorphisms (SNPs) of the resistin gene on the plasma resistin concentration and cardiovascular risk factors. Methods and results: Plasma resistin concentrations were measured and SNP -420
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:2755-2760
Resistin is a newly described hormone with a suggested role in insulin resistance. In humans, inflammatory cells seem to be the major source of resistin. The aim of this study was to find out whether plasma resistin concentration associates with caro
Publikováno v:
Atherosclerosis Supplements. 8:184